Related references
Note: Only part of the references are listed.Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
Doron Lipson et al.
NATURE MEDICINE (2012)
KIF5B-RET fusions in lung adenocarcinoma
Takashi Kohno et al.
NATURE MEDICINE (2012)
Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants
Cathy Quelen et al.
BLOOD (2011)
Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
Ayalew Tefferi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
Elaine T. Lam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Renal aplasia in humans is associated with RET mutations
Michael A. Skinner et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
RET/PTC activation in papillary thyroid carcinoma: European journal of endocrinology prize lecture
Massimo Santoro et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Current concepts in RET-related genetics, signaling and therapeutics
Ivan Plaza-Menacho et al.
TRENDS IN GENETICS (2006)
BAY 43-9006 inhibition of oncogenic RET mutants
F Carlomagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl
O Hantschel et al.
MOLECULAR CELL (2005)
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma
RM Melillo et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition
C Dorrell et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
BJP Huntly et al.
CANCER CELL (2004)
Finishing the euchromatic sequence of the human genome
FS Collins et al.
NATURE (2004)
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
E Beillard et al.
LEUKEMIA (2003)
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: Roles in specific gene regulation and cellular transformation
JH Hwang et al.
MOLECULAR ENDOCRINOLOGY (2003)
New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophilia
MC Cox et al.
LEUKEMIA RESEARCH (2001)
Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor
H Hayashi et al.
ONCOGENE (2000)
Share Paper
